---  
layout: startup_page  
title: "Tr1X"  
id: "tr1x.bio"  
permalink: "/tr1xtr1x.bio01172024/"  
website: "https://www.tr1x.bio/"  
funding_round: "Series A"  
funding_amount: "$75M"  
investors: "The Column Group, NEVA SGR, Alexandria Ventures"  
about: "Tr1X, Inc. is a biotechnology company developing universal allogeneic cell therapies to treat autoimmune and inflammatory diseases. Their therapies are based on engineered Tr1 cells, derived from universal donors, offering a potential cure instead of lifelong treatment. Tr1X has a scalable GMP-grade manufacturing process to produce these therapies at commercial volume."  
markets: "Biotechnology, Cell Therapy, Immunotherapy"  
hq: "San Diego, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/tr1x"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/tr1x"  
pitchbook: "https://pitchbook.com/profiles/company/433085-41"  

date_display: "17-Jan-2024"  
date: "2024-01-17"

# SEO Optimization  
meta_title: "Tr1X - Series A Funding ($75M)"  
meta_description: "Tr1X, Tr1X, Inc. is a biotechnology company developing universal allogeneic cell therapies to treat autoimmune and inflammatory diseases. Their therapies ar..."  
meta_keywords: "Tr1X, Biotechnology, Cell Therapy, Immunotherapy, Series A funding"  
canonical_url: "https://startup.projectstartups.com/tr1xtr1x.bio01172024/"  
---